Oncology CPT® Codes for 2026 + Modifiers
Jan 27, 2026
Technically Reviewed By:
Last Updated: November 4, 2026
Kristen is a Senior Account Manager with 25 years of experience in the healthcare industry. She specializes in commercial insurance resolution, helping practices navigate payer disputes, denials, audits, and other revenue challenges.
Oncology billing spans complex consultations, chemotherapy administration, immunotherapy, radiation therapy, infusion services, drug wastage reporting, and high-cost treatment delivery. In 2026, oncology faces one of the most significant CPT® restructures in years, particularly in radiation oncology and supportive chemotherapy care. Using the correct oncology CPT® codes and modifiers for 2026 is essential to prevent denials, protect revenue, and stay compliant in a highly scrutinized specialty. Each code below has been checked against current CMS and AMA sources.
Oncology denials aren’t random. They’re driven by documentation gaps, modifier errors, and the 2026 radiation changes.
We consistently see rejected claims tied to incorrect radiation delivery coding, missing -JW/-JZ drug modifiers, infusion time documentation gaps, and improper E/M billing alongside chemotherapy. These are predictable denial triggers, and preventable.
Guarantee: We’ll identify the top denial causes in your oncology claims and provide a clear action plan to correct them.
Get My Oncology Denial Snapshot
Contact us to receive a Denial Snapshot showing why your oncology claims aren’t getting paid, and how to fix them.
Evaluation & Management (E/M) Codes for Oncology
Oncology care frequently involves complex decision-making, treatment planning, symptom management, and advance care planning. When chemotherapy or infusion services happen on the same day as an office visit, the E/M documentation must stand on its own to justify separate payment.
| CPT® Code | Description |
|---|---|
| 99202–99205 | New patient office visits: straightforward (15 min), low (30 min), moderate (45 min), high MDM (60 min) |
| 99211–99215 | Established patient office visits: 99212 straightforward (10 min), 99213 low (20 min), 99214 moderate (30 min), 99215 high MDM (40 min) |
| 99221–99223 | Initial hospital inpatient or observation care |
| 99231–99233 | Subsequent hospital inpatient or observation care |
| 99238–99239 | Hospital inpatient or observation discharge |
| 99497 / +99498 | Advance care planning, first 30 minutes (report at 16 minutes or more) / each additional 30 minutes |
| +G2211 | Medicare add-on for visit complexity in ongoing care of a serious or complex condition, added to an office E/M visit |
Documentation tip: When billing E/M on the same day as chemotherapy administration, document a significant, separately identifiable service beyond the routine pre-treatment assessment to support modifier -25. Don’t add G2211 to a visit billed with -25 on a chemotherapy day.
E/M plus chemo denials happen when the documentation doesn’t tell a separate story.
Payers heavily scrutinize 99213–99215 billed with infusion or chemo codes. Without clear assessment and decision-making documentation, claims deny as bundled.
Guarantee: We’ll pinpoint exactly why your E/M claims are denied and show you how to correct them.
Contact us for an oncology-specific E/M denial review.
Chemotherapy and Therapeutic Infusions
Chemotherapy and infusion coding follows strict initial-service and time rules. Incorrect sequencing, incomplete time documentation, or misuse of additional-hour codes commonly leads to denials.
| CPT® Code | Description |
|---|---|
| 96413 | Chemotherapy IV infusion, up to 1 hour, single or initial drug |
| +96415 | Chemotherapy IV infusion, each additional hour |
| +96417 | Chemotherapy IV infusion, each additional sequential infusion of a different drug, up to 1 hour |
| 96409 | Chemotherapy IV push, single or initial drug |
| +96411 | Chemotherapy IV push, each additional sequential drug |
| 96401 / 96402 | Chemotherapy subcutaneous or intramuscular injection; non-hormonal / hormonal anti-neoplastic |
| 96365 | Therapeutic, prophylactic or diagnostic IV infusion, initial, up to 1 hour |
| +96366 | Each additional hour |
| +96367 | Additional sequential infusion of a new drug, up to 1 hour |
| +96368 | Concurrent infusion |
| 96374 / +96375 | Therapeutic IV push, single or initial drug / each additional sequential push of a new drug |
| 96360 / +96361 | IV hydration, initial 31 minutes to 1 hour / each additional hour |
Initial service and hierarchy: For facility (hospital) claims, the initial code follows the hierarchy: chemotherapy first, then therapeutic or diagnostic infusions and pushes, then hydration. For physician office claims, the initial code is the service that best reflects the main reason for the encounter. Report only one initial service per encounter unless a separate IV site is required.
Time rules: An infusion of 15 minutes or less is reported as a push. Add an additional-hour code (96415, 96366, 96361) only when the infusion runs more than 30 minutes past the first hour. Hydration must last more than 30 minutes to be reported.
Infusion time errors are one of the most common oncology denial drivers.
If start and stop times aren’t documented precisely, or additional-hour thresholds aren’t met, claims deny or get downcoded.
Guarantee: We’ll identify infusion documentation gaps costing you reimbursement.
Contact us to analyze infusion-related denials.
Pumps, Intracavitary and HIPEC Chemotherapy
| Code | Description |
|---|---|
| 96416 | Chemotherapy infusion, initiation of prolonged infusion (more than 8 hours) requiring a portable or implantable pump |
| G0498 | Medicare: chemotherapy IV infusion started in the office and continued at home on a portable pump the office provides, including the follow-up visit when the infusion ends |
| 96521 / 96522 | Refilling and maintenance of a portable pump / an implantable pump or reservoir |
| 96446 | Chemotherapy administration into the peritoneal cavity via an indwelling port or catheter |
| +96547 / +96548 | Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), first 60 minutes / each additional 30 minutes |
New for 2026: Mechanical Scalp Cooling (Chemo Support Care)
Mechanical scalp cooling now has permanent Category I CPT® codes, replacing Category III codes 0662T and 0663T. The device must be an FDA-defined medical device used in the office or facility and run by trained clinical staff; these codes aren’t reported when the patient self-administers scalp cooling.
| CPT® Code | Description |
|---|---|
| 97007 | Mechanical scalp cooling; initial measurement and calibration of cap (once per chemotherapy treatment period, not each session) |
| 97008 | Mechanical scalp cooling, including hair preparation, cap placement, therapy initiation and pre-cooling period (once per chemotherapy session) |
| +97009 | Mechanical scalp cooling after chemotherapy ends, each 30 minutes (add-on to 97008; not reported for less than 16 minutes) |
New codes mean new denial risks.
If your team hasn’t updated templates and charge capture for 97007–97009, rejected claims are likely.
Guarantee: We’ll confirm your workflows support proper reporting of scalp cooling services.
Radiation Oncology: The 2026 Technique-Agnostic “Complexity” Overhaul
External beam radiation treatment delivery is now billed by complexity level, not technique, in both hospital and freestanding settings. This is a major structural shift.
Deleted for 2026: 77385 and 77386 (IMRT delivery), 77014 (CT guidance), 77401 (superficial delivery), and Medicare’s delivery G-codes G6001–G6017.
| CPT® Code | Complexity Level | What it covers |
|---|---|---|
| 77402 | Level 1 | Single or multiple electron fields, or 2D photons; includes imaging guidance when performed |
| 77407 | Level 2 | Single-isocenter photon therapy (for example, 3D or IMRT); includes imaging guidance when performed |
| 77412 | Level 3 | Multiple isocenters with photon therapy, or a single isocenter with active motion management; includes imaging guidance when performed |
Bundling alert: Technical image guidance is now included in 77402–77412. Superficial and orthovoltage treatment moved to the new surface radiation codes 77436–77439.
| CPT® Code | Description |
|---|---|
| 77261–77263 | Radiation therapy treatment planning: simple, intermediate, complex |
| 77280 / 77290 | Simulation-aided field setting: simple / complex |
| 77295 | 3D radiotherapy plan, including dose-volume histograms |
| 77300 | Basic radiation dosimetry calculation |
| 77301 / 77338 | IMRT plan / multileaf collimator device design for IMRT |
| 77427 | Radiation treatment management, 5 treatments |
Billing deleted radiation codes will trigger automatic rejections.
If your system still uses 77385, 77386, 77014, 77401 or the G60xx delivery codes, those claims won’t pay in 2026.
Guarantee: We’ll audit your radiation coding transition for compliance risk.
2026 Change: Professional Image Guidance Code (77387)
Image guidance for all external beam delivery is now reported with a single code, 77387, and only the professional part is separately payable. Bill 77387 with modifier -26; the technical component is bundled into the delivery codes.
Tumor Genomic Sequencing Codes
| CPT® Code | Description |
|---|---|
| 81445 / 81449 | Targeted genomic sequence panel, solid organ neoplasm, 5–50 genes; DNA or DNA and RNA / RNA analysis |
| 81450 / 81451 | Targeted genomic sequence panel, hematolymphoid neoplasm, 5–50 genes; DNA or DNA and RNA / RNA analysis |
| 81455 / 81456 | Genomic sequence panel, solid organ or hematolymphoid neoplasm, 51 or more genes; DNA or DNA and RNA / RNA analysis |
| 81457–81459 | Solid organ neoplasm panels with microsatellite instability, adding copy number variants, tumor mutation burden and rearrangements as the code level increases |
| 81462–81464 | Solid organ neoplasm panels using cell-free nucleic acid (liquid biopsy), with increasing analysis levels |
These tests are usually billed by the performing laboratory, not the oncology practice. Practices still need to document the order and medical necessity.
Oncology Modifiers for 2026
| Modifier | Description |
|---|---|
| -25 | Significant, separately identifiable E/M on the same day as a procedure or drug administration |
| -59 / -XS / -XE | Distinct procedural service; -XS separate structure; -XE separate encounter. CMS prefers the -X modifiers when one applies (for example, a second IV site). |
| -76 | Repeat procedure by the same physician |
| -91 | Repeat clinical diagnostic laboratory test (lab tests only) |
| -JW | Amount of a single-dose drug discarded, on a separate line |
| -JZ | Required when none of a single-dose drug was discarded |
| -TB | 340B-acquired drug (replaced -JG for all 340B covered entities on January 1, 2025) |
| -FS | Split/shared visit between a physician and NPP in the same group |
| -FT | Unrelated E/M during a postoperative period or on the same day as another E/M |
| -26 / -TC | Professional component / technical component |
Common ICD-10 Codes in Oncology
| ICD-10 Code | Description |
|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C61 | Malignant neoplasm of prostate |
| C20 | Malignant neoplasm of rectum |
| C18.9 | Malignant neoplasm of colon, unspecified |
| D05.01 / D05.11 | Lobular / intraductal carcinoma in situ of right breast |
| Z51.11 | Encounter for antineoplastic chemotherapy |
| Z51.12 | Encounter for antineoplastic immunotherapy |
| D63.0 | Anemia in neoplastic disease |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
2026 Oncology Billing & Compliance Tips
- Use -JW or -JZ on every applicable single-dose drug line, and -TB (not -JG) for 340B-acquired drugs.
- Document infusion start and stop times precisely, and meet the 31-minute threshold before adding an additional hour.
- Follow the facility hierarchy on hospital claims and the primary-reason rule on physician claims.
- Code radiation delivery by complexity level, and bill image guidance as 77387-26 only.
- Remove 77385, 77386, 77014, 77401 and G6001–G6017 from charge masters, and report 97007 only once per chemotherapy treatment period.
Frequently Asked Questions
What are the radiation oncology CPT codes for 2026?
External beam delivery is billed with 77402 (Level 1), 77407 (Level 2) or 77412 (Level 3), and image guidance with 77387-26. The IMRT delivery codes 77385 and 77386 were deleted.
What are the main chemotherapy infusion CPT codes?
Use 96413 for the first hour of a chemotherapy infusion, 96415 for each additional hour, 96417 for each sequential infusion of a different drug, and 96409/96411 for IV push.
What is the CPT code for an oncology consultation?
Many commercial payers accept office consultation codes 99242–99245. Medicare doesn’t pay consultation codes, so bill new patient visits 99202–99205 instead.
Final Thoughts
Oncology billing in 2026 demands strict compliance with modifier reporting, infusion rules, drug wastage documentation, and the radiation delivery restructuring. Keeping your CPT® codes and documentation aligned with current standards protects revenue and reduces preventable denials. Contact Quest National Services to review your oncology claims.
Trademark notice: CPT is a registered trademark of the American Medical Association.
For informational purposes only.

